Literature DB >> 12033770

Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines.

Alberto L van Olphen1, Suresh K Tikoo, Suresh K Mittal.   

Abstract

Like human adenovirus type 5 (HAV5), bovine adenovirus type 3 (BAV3) early region 1 (E1) consists of E1A and E1B transcriptional units. In order to characterize BAV3 E1 proteins and to isolate a cell line of bovine origin that expresses BAV3 E1, polyclonal antibodies specific to E1A, E1B-157R, and E1B-420R were raised in rabbits. BAV3 E1A, E1B-157R, and E1B-420R were identified as 40, 17, and 47 kDa proteins, and had a half-life of 45-60 min, and 4-6 and 4-6 h, respectively. It appeared that E1A and E1B-157R were phosphorylated at the serine/threonine residues, whereas, E1B 420R was phosphorylated at both the serine/threonine and tyrosine residues. Three cell lines, MDBK-221 (Madin Darby bovine kidney (MDBK) transfected with BAV3 E1), FBK-34 (primary fetal bovine kidney (FBK) cells transfected BAV3 E1), and FBRT-HE1 (bovine fetal retinal (FBRT) cells transfected with HAV5 E1) were isolated and characterized for E1 expression. FBK-34 or FBRT-HE1 supported the replication of an E1A-deleted BAV3 (BAV3DeltaE1AE3) to approximately 1-2 x 10(8) PFU/ml, whereas, the virus titers in MDBK-221 were approximately 10(7) PFU/ml. These cell lines will be useful in generating and growing BAV3 E1-deleted recombinants, and also for studying E1 protein interactions with a number of cellular and/or viral proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033770     DOI: 10.1006/viro.2002.1389

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  Current strategies and future directions for eluding adenoviral vector immunity.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2006-04       Impact factor: 4.391

2.  155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication.

Authors:  Ahmed O Hassan; Sai V Vemula; Anurag Sharma; Dinesh S Bangari; Krishna K Mishra; Suresh K Mittal
Journal:  J Gen Virol       Date:  2017-04-27       Impact factor: 3.891

3.  Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.

Authors:  Anurag Sharma; Dinesh S Bangari; Sai V Vemula; Suresh K Mittal
Journal:  Virus Res       Date:  2011-08-16       Impact factor: 3.303

4.  Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Harm Hogenesch; Suresh K Mittal
Journal:  Virus Res       Date:  2010-07-24       Impact factor: 3.303

Review 5.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

6.  Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer.

Authors:  Manish Tandon; Anurag Sharma; Sai V Vemula; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2011-09-29       Impact factor: 3.303

7.  Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Aseem Pandey; Harm HogenEsch; Suresh K Mittal
Journal:  Virology       Date:  2009-02-10       Impact factor: 3.616

8.  Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry.

Authors:  Xiaoxin Li; Dinesh S Bangari; Anurag Sharma; Suresh K Mittal
Journal:  Virology       Date:  2009-07-30       Impact factor: 3.616

9.  Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.

Authors:  Neetu Singh; Aseem Pandey; Lakshmi Jayashankar; Suresh K Mittal
Journal:  Mol Ther       Date:  2008-02-26       Impact factor: 11.454

10.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.